And Irvine


AMSTERDAM, The Netherlands, and IRVINE, California, June 9, 2011 - Agendia, a commercial-stage molecular cancer diagnostics company, announces today that it has entered into a research collaboration with The University of Texas MD Anderson Cancer Center, one of the world's leading cancer centers and whose research program is considered one of the most productive in the world aimed solely at cancer, and the Netherlands Cancer Institute (NKI) with the aim of improving diagnosis and treatment options of colorectal cancer patients.
Older News
S M T W T F S
22 23 24 25 26 27 28
29 30 31 1 2 3 4
5 6 7 8 9 10 11
Copyright© 2011 The Gaea Times